US Patent Issued to SHENZHEN IN VIVO BIOMEDICINE TECHNOLOGY on Dec. 23 for "Chimeric antigen receptor for recognizing Fc fragment and application thereof" (Chinese Inventors)

ALEXANDRIA, Va., Dec. 23 -- United States Patent no. 12,502,405, issued on Dec. 23, was assigned to SHENZHEN IN VIVO BIOMEDICINE TECHNOLOGY Ltd. COMPANY (Guangdong, China).

"Chimeric antigen receptor for recognizing Fc fragment and application thereof" was invented by Peng Li (Guangdong, China), Yuanbin Cui (Guangdong, China), Zhaoyang Tang (Guangdong, China), Shanglin Li (Guangdong, China), Yao Yao (Guangdong, China) and Simiao Lin (Guangdong, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "A chimeric antigen receptor for recognizing an Fc fragment and an application thereof. The chimeric antigen receptor comprises an antigen binding domain, a transmembrane domain, and an intracellular costimulatory si...